Is combined treatment with fenofibrate and ezetimibe safe and efficacious in patients with mixed hyperlipidemia?

被引：3
|
作者：
Davidson, Michael H.
机构：
[1] Radiant Res, Chicago, IL 60610 USA
[2] Rush Univ, Med Ctr, Chicago, IL USA
来源：
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE | 2006年 / 3卷 / 11期
关键词：
ezetimibe; fenofibrate; hyperlipidemia;
D O I：
10.1038/ncpcardio0689
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：594 / 595
页数：2
相关论文
共 50 条
  • [41] Effects of micronized fenofibrate on apo A defined HDL subfractions in patients with combined hyperlipidemia
    Branchi, A
    Rovellini, A
    Fiorenza, AM
    Sommariva, D
    ATHEROSCLEROSIS, 1998, 138 : S8 - S8
  • [42] Meta-Analysis of Safety of the Coadministration of Statin With Fenofibrate in Patients With Combined Hyperlipidemia
    Guo, Jinrui
    Meng, Fanbo
    Ma, Ning
    Li, Chunhua
    Ding, Zhenjiang
    Wang, Hong
    Hou, Ruitian
    Qin, Yingjie
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (09): : 1296 - 1301
  • [43] Effects of addition of fenofibrate in high risk patients with combined hyperlipidemia not controlled by pravastatin
    Ducobu, J.
    Farnier, M.
    Bryniarshi, L.
    DIABETES & METABOLISM, 2007, 33 : S60 - S60
  • [44] Effects of adding fenofibrate in high risk patients with combined hyperlipidemia not controlled by pravastatin
    Farnier, M.
    Ducobu, J.
    Bryniarski, L.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 554 - 554
  • [45] Effects of co-administered ezetimibe and fenofibrate in mixed dyslipidaemic patients with metabolic syndrome
    Davies, M. J.
    Bays, H. E.
    Shah, A.
    Macdonell, G.
    Gumbiner, B.
    DIABETOLOGIA, 2006, 49 : 452 - 453
  • [46] EZETIMIBE IMPROVES POSTPRANDIAL HYPERLIPIDEMIA IN PATIENTS WITH TYPE IIB HYPERLIPIDEMIA
    Inagaki, M.
    Masuda, D.
    Nakatani, K.
    Tsubakio-Yamamoto, K.
    Ohama, T.
    Nakagawa-Toyama, Y.
    Nishida, M.
    Ishigami, M.
    Yamashita, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [47] EFFECTS OF A FIXED COMBINATION OF FENOFIBRATE AND PRAVASTATIN ON APOLIPOPROTEINS IN HIGH RISK PATIENTS WITH MIXED HYPERLIPIDEMIA
    Ducobu, J.
    Farnier, M.
    Fruchart, J. C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 193 - 193
  • [48] Ezetimibe/simvastatin - A combination product for the treatment of hyperlipidemia
    Coleman, CI
    Lindberg, M
    Perkerson, KA
    White, M
    FORMULARY, 2004, 39 (09) : 437 - +
  • [49] Comparative efficacy of fenofibrate/pravastatin/ezetimibe and simvastatin/ezetimibe therapies in type 2 diabetic patients with combined hyperlipidaemia and cardiovascular disease
    Farnier, M.
    Steinmetz, A.
    Csaszar, A.
    Retterstol, K.
    Dluzniewski, M.
    DIABETOLOGIA, 2010, 53
  • [50] INFLUENCE OF EZETIMIBE AND CO-ADMINISTRATION OF EZETIMIBE/SIMVASTATIN ON POSTPRANDIAL HYPERLIPIDEMIA IN PATIENTS WITH PRIMARY HYPERLIPIDEMIA.
    Bubnova, M.
    Aronov, D.
    ATHEROSCLEROSIS, 2019, 287 : E205 - E205
12345